|
6MF0
Crystal Structure Determination of Human/Porcine Chimera Coagulation Factor VIII
Deposited 2018-09-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: monomeric
|
Chain A
1–386(386 aa)
Fragment:UNP residues 1-386 (pig), 387-761 (human), 762-771,1438-1820 (pig), 2039-2351 (human)
Chain A
762–771(10 aa)
Fragment:UNP residues 1-386 (pig), 387-761 (human), 762-771,1438-1820 (pig), 2039-2351 (human)
Chain A
1438–1820(383 aa)
Fragment:UNP residues 1-386 (pig), 387-761 (human), 762-771,1438-1820 (pig), 2039-2351 (human)
Chain B
1–386(386 aa)
Fragment:UNP residues 1-386 (pig), 387-761 (human), 762-771,1438-1820 (pig), 2039-2351 (human)
Chain B
762–771(10 aa)
Fragment:UNP residues 1-386 (pig), 387-761 (human), 762-771,1438-1820 (pig), 2039-2351 (human)
Chain B
1438–1820(383 aa)
Fragment:UNP residues 1-386 (pig), 387-761 (human), 762-771,1438-1820 (pig), 2039-2351 (human)
|
Not recorded
|
CA CALCIUM ION × 2
ZN ZINC ION × 2
CU1 COPPER (I) ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;16% PEG3350, 0.025 M magnesium chloride, 0.025 M HEPES
|
Resolution 3.20 Å
R-free 0.287
|
|
6MF0
Crystal Structure Determination of Human/Porcine Chimera Coagulation Factor VIII
Deposited 2018-09-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–386(386 aa)
Fragment:UNP residues 1-386 (pig), 387-761 (human), 762-771,1438-1820 (pig), 2039-2351 (human)
Chain A
762–771(10 aa)
Fragment:UNP residues 1-386 (pig), 387-761 (human), 762-771,1438-1820 (pig), 2039-2351 (human)
Chain A
1438–1820(383 aa)
Fragment:UNP residues 1-386 (pig), 387-761 (human), 762-771,1438-1820 (pig), 2039-2351 (human)
|
Not recorded
|
CA CALCIUM ION × 1
ZN ZINC ION × 1
CU1 COPPER (I) ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;16% PEG3350, 0.025 M magnesium chloride, 0.025 M HEPES
|
Resolution 3.20 Å
R-free 0.287
|
|
7K66
Structure of Blood Coagulation Factor VIII in Complex with an Anti-C1 Domain Pathogenic Antibody Inhibitor
Deposited 2020-09-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–405(405 aa)
Chain A
1438–1820(383 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CU COPPER (II) ION × 1
CA CALCIUM ION × 1
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.7;293 K;17.5 %(w/v) PEG 1500, 50 mM HEPES (pH 7.7)
|
Resolution 3.92 Å
R-free 0.322
|
|
7KBT
Factor VIII in complex with the anti-C2 domain antibody, G99
Deposited 2020-10-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–386(386 aa)
Chain A
762–771(10 aa)
Chain A
1438–1820(383 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CU COPPER (II) ION × 1
ZN ZINC ION × 1
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;8 - 18% PEG 1500, PEG 6K, or PEG 10K and 50mM malic acid, pH 7.
|
Resolution 4.15 Å
R-free 0.338
|
|
7S0P
Crystal structure of Porcine Factor VIII C2 Domain Bound to Phosphatidylserine
Deposited 2021-08-30
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain M
1974–2129(156 aa)
|
Not recorded
|
SEP PHOSPHOSERINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;2:1 drop ratio
0.1 M CHES (pH 7.4)
0.1M magnesium acetate
10% ethanol (v/v)
Crystal soaked with 5 mM OPLS
|
Resolution 1.30 Å
R-free 0.156
|
|
8G6I
Coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor
Deposited 2023-02-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–405(405 aa)
Chain A
1438–1820(383 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;150 mM NaCl, 20 mM HEPES pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.23 Å
|
|
8TY1
Cryo-EM structure of coagulation factor VIII bound to NB2E9
Deposited 2023-08-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–391(391 aa)
Chain A
1438–1820(383 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;20 mM HEPES (pH 7.4) and 150 mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.46 Å
|